Cargando…

AFP ratio predicts HCC recurrence after liver transplantation

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is a leading indication for liver transplantation (LT) worldwide. Early identification of patients at risk for HCC recurrence is of paramount importance since early treatment of recurrent HCC after LT may be associated with increased survival. We evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koch, Christine, Bette, Theresa, Waidmann, Oliver, Filmann, Natalie, Schrecker, Christopher, Trojan, Jörg, Weiler, Nina, Vermehren, Johannes, Schnitzbauer, Andreas A., Bechstein, Wolf Otto, Zeuzem, Stefan, Herrmann, Eva, Welker, Martin-Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332004/ https://www.ncbi.nlm.nih.gov/pubmed/32614912 http://dx.doi.org/10.1371/journal.pone.0235576

Ejemplares similares

Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma
por: Schrecker, Christopher, et al.
Publicado: (2022)

Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis
por: Schulz, Martin S., et al.
Publicado: (2022)

Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates
por: Ferstl, Philip G., et al.
Publicado: (2021)

Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma
por: Koch, Christine, et al.
Publicado: (2019)

Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
por: Koch, Christine, et al.
Publicado: (2021)

Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates
por: Zmuc, Jan, et al.
Publicado: (2023)

Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms
por: Ferstl, Philip G, et al.
Publicado: (2018)

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis
por: Finkelmeier, Fabian, et al.
Publicado: (2018)

Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases
por: Wang, Ting, et al.
Publicado: (2017)

Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC
por: Liu, Zijing, et al.
Publicado: (2021)

Point Shear‐Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver‐Related Events in Patients With Chronic Viral Hepatitis
por: Hernandez Sampere, Lisa, et al.
Publicado: (2020)

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study
por: Kronenberger, Bernd, et al.
Publicado: (2012)

Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
por: Weiler, Nina, et al.
Publicado: (2016)

Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy
por: Kinzler, Maximilian N., et al.
Publicado: (2022)

Indication for ‘Over the Scope’ (OTS)-Clip vs. Covered Self-Expanding Metal Stent (cSEMS) Is Unequal in Upper Gastrointestinal Leakage: Results from a Retrospective Head-to-Head Comparison
por: Farnik, Harald, et al.
Publicado: (2015)

Study protocol for a pilot trial analysing the usability, validity and safety of an interventional health app programme for the structured prehabilitation of patients before major surgical interventions: the PROTEGO MAXIMA trial
por: Faqar-Uz-Zaman, Sara Fatima, et al.
Publicado: (2023)

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
por: Trojan, Jörg, et al.
Publicado: (2016)

Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations
por: Zhao, Ting, et al.
Publicado: (2020)

AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy
por: Watanabe, Takao, et al.
Publicado: (2021)

Prognostic value of des-γ-carboxyprothrombin in patients with AFP-negative HCC treated with TACE
por: Sun, Hanyao, et al.
Publicado: (2022)

Survival According to Therapy Regimen for Small Intestinal Neuroendocrine Tumors
por: Koch, Christine, et al.
Publicado: (2022)

AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway
por: Chen, Tianke, et al.
Publicado: (2020)

Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
por: Beudeker, Boris J.B., et al.
Publicado: (2023)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
por: Schultze, Tilman G., et al.
Publicado: (2021)

Study protocol for a prospective, double-blinded, observational study investigating the diagnostic accuracy of an app-based diagnostic health care application in an emergency room setting: the eRadaR trial
por: Faqar-Uz-Zaman, S Fatima, et al.
Publicado: (2021)

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients
por: Sun, Xuqi, et al.
Publicado: (2021)

Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population
por: Zheng, Kepu, et al.
Publicado: (2023)

Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
por: Wang, Yuliang, et al.
Publicado: (2011)

AFP
Publicado: (2009)

Volume and outcome relation in German liver transplant centers: what lessons can be learned?
por: Nijboer, Annemarie, et al.
Publicado: (2014)

Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy
por: Ma, Wen-jun, et al.
Publicado: (2013)

Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds
por: Song, Ting, et al.
Publicado: (2020)

Inflammation-Related Marker NrLR Predicts Prognosis in AFP-Negative HCC Patients After Curative Resection
por: Wu, Qionglan, et al.
Publicado: (2023)

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis
por: SCHULZE, BJÖRN, et al.
Publicado: (2014)

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy
por: Dietz, Julia, et al.
Publicado: (2016)

Baseline MELD Score Predicts Hepatic Decompensation during Antiviral Therapy in Patients with Chronic Hepatitis C and Advanced Cirrhosis
por: Dultz, Georg, et al.
Publicado: (2013)

Association of Common Variants in HNF1A Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients
por: Li, Xue-jun, et al.
Publicado: (2019)

Integrated analysis of the rhesus monkey liver transcriptome during development and human primary HCC AFP-related gene expression
por: Feng, Lin, et al.
Publicado: (2021)

The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
por: Zhang, Da-li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2gkoub0knp0n8oqbivbu60bdbc